Repligen Corporation (RGEN) vs Teleflex Incorporated (TFX)

Repligen Corporation and Teleflex Incorporated are both Medical Instruments & Supplies companies. Repligen Corporation is the larger, with a market value of $10.8B against $6.5B — 1.7× the size. Teleflex Incorporated grew revenue faster over the last twelve months: 30.7% against 13.8%. Repligen Corporation has the higher net margin (−1.47% vs −45.8%) and the higher return on invested capital (0.64% vs 0.51%). Across the 21 metrics below, Repligen Corporation leads on 12 and Teleflex Incorporated on 9.

Valuation

Metric RGEN TFX Medical Instruments & Supplies median
P/E n/m n/m 30.28
P/S 11.87 2.94 2.49
P/B 4.57 2.28 2.34
Price to free cash flow 170.11 124.77 23.49
EV/EBITDA 60.12 35.66 14.87
EV/Sales 11.57 4.05 2.75
Earnings yield (0.12%) (15.30%) 0.00%
Free cash flow yield 0.59% 0.80% 0.59%

Profitability

Metric RGEN TFX Medical Instruments & Supplies median
Gross margin 53.46% 54.94% 53.60%
Operating margin 2.26% 1.97% 1.97%
Net margin (1.47%) (45.76%) 0.00%
Free cash flow margin 13.09% 2.36% 2.36%
Return on equity (0.57%) (28.87%) 0.00%
Return on assets (0.40%) (14.57%) 0.00%
Return on invested capital 0.64% 0.51% 0.13%

Growth

Metric RGEN TFX Medical Instruments & Supplies median
Revenue growth (TTM) 13.80% 30.70% 8.97%
EPS growth (last fiscal year) 286.96% (1,468.24%) 6.51%
Revenue growth, 5-year CAGR 15.05% (4.72%) 8.85%
Net income growth, 5-year CAGR (3.99%) 0.00% 0.00%

Health

Metric RGEN TFX Medical Instruments & Supplies median
Debt to equity 0.27 0.97 0.10
Current ratio 9.88 2.60 2.47
Net debt to EBITDA (1.50) 7.52 0.97

Dividend

Metric RGEN TFX Medical Instruments & Supplies median
Dividend yield — 0.89% 1.02%
Payout ratio — — 0.27

Size

Metric RGEN TFX Medical Instruments & Supplies median
Market cap 10.77b 6.45b 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack